Literature DB >> 18699846

High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy.

Miguel Bispo1, Paulo Marcelino, António Freire, Américo Martins, Luís Mourão, Eduardo Barroso.   

Abstract

Early thrombotic complications are critical causes of in-hospital morbidity after orthotopic liver transplantation (OLT), potentially culminating in graft loss. The aim of this study was to retrospectively analyse these complications, trying to identify associated independent risk factors. This retrospective analysis included 223 OLTs performed on 213 patients, in a 30-month period. Eighty-six OLTs were performed on familial amyloidotic polyneuropathy (FAP) patients. Preoperative details (primary diagnosis and Child-Turcotte-Pugh classification, when applicable), surgical features (including type of arterial reconstruction), postoperative variables and outcome were analysed. The observation period ended 30 days post-OLT, until discharge or in-hospital death. Early thrombotic complications were diagnosed in 16 cases (7.2%), affecting mainly FAP patients (n = 12). Hepatic artery thrombosis (HAT) was the most frequent early thrombotic event (n = 12): incidence in FAP patients 11.6% (n = 10) versus incidence in non FAP patients 1.5% (n = 2), P = 0.001. By logistic regression analysis, FAP turned out to be an independent risk factor for early thrombotic complications, and specifically for HAT. The type of arterial reconstruction and other analysed surgical and medical factors did not influence early HAT occurrence. In conclusion, FAP was identified in this study as an independent risk factor for early HAT, a new datum not yet described in the literature.

Entities:  

Mesh:

Year:  2008        PMID: 18699846     DOI: 10.1111/j.1432-2277.2008.00737.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

Review 1.  Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.

Authors:  Adam Castaño; Sabahat Bokhari; Thomas H Brannagan; Julia Wynn; Mathew S Maurer
Journal:  Amyloid       Date:  2011-12-08       Impact factor: 7.141

Review 2.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

3.  Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells.

Authors:  Raquel J Nunes; Paula de Oliveira; Ana Lages; Jörg D Becker; Paulo Marcelino; Eduardo Barroso; Rui Perdigoto; Jeffery W Kelly; Alexandre Quintas; Susana Constantino Rosa Santos
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

4.  Perioperative Thromboelastometry for Adult Living Donor Liver Transplant Recipients with a Tendency to Hypercoagulability: A Prospective Observational Cohort Study.

Authors:  Yasmin Kamel; Ashraf Hassanin; Abdel Rahman Ahmed; Emad Gad; Mohamed Afifi; Magdy Khalil; Klaus Görlinger; Khaled Yassen
Journal:  Transfus Med Hemother       Date:  2018-08-24       Impact factor: 3.747

5.  Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients.

Authors:  Rosa Ayala; Joaquín Martínez-López; Teresa Cedena; Rosalía Bustelos; Carlos Jimenez; Enrique Moreno; Carmen Ribera
Journal:  BMC Gastroenterol       Date:  2011-11-28       Impact factor: 3.067

Review 6.  Molecular Mechanisms of Cardiac Amyloidosis.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Hiroshi Ito
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 7.  Evolving landscape in the management of transthyretin amyloidosis.

Authors:  Philip N Hawkins; Yukio Ando; Angela Dispenzeri; Alejandra Gonzalez-Duarte; David Adams; Ole B Suhr
Journal:  Ann Med       Date:  2015-11-27       Impact factor: 4.709

8.  Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.

Authors:  Ole B Suhr; Marie Larsson; Bo-Göran Ericzon; Henryk E Wilczek
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

9.  Approach to the liver transplant early postoperative period: an institutional standpoint.

Authors:  Beatriz Amaral; Madalena Vicente; Carla Sofia Maravilha Pereira; Teresa Araújo; Ana Ribeiro; Rui Pereira; Rui Perdigoto; Paulo Marcelino
Journal:  Rev Bras Ter Intensiva       Date:  2019 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.